| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Investing > Mortgage Meltdown and Kiyosaki Predictions |
|
Top Articles - Mortgage Meltdown and Kiyosaki Predictions
I heard a great article on the hot topic, the Mortgage Meltdown, on NPR.org. If you want another interesting According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product take, read about it on CBS.com. The question that the Mortgage Meltdown begs is whether or not there is a big ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er real estate dip on the horizon as predicted by Robert Kiyosaki. Since interest rates were so low in 2001- lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. 2005, mortgage companies were giving sub-prime buyers a 100% home loan on a variable note with the recommenda here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ion that they refinance that variable note later. Since the housing market isn't moving very fast, and intere d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t rates are climbing, it has caused a rash of foreclosures as payments climb faster than income. So far, the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc current mortgage bust is something I would call typical of an upturning economy. It's typical because the in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi erest rate always match the economy, and the buying trends always follow the interest rate. So when rates wer nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e low, buyers bought ARMs (Variable rate loans). Now that rates are going up, buyers have to switch to Fixed and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ates. Because of supply and demand, the ripple of foreclosures should pull the entire spread of real estate v ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi lues down for a little while. This 'meltdown' points to an article by Robert Kiyosaki about a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a //www.hachettebookgroupusa.com/authorslounge/articles/2005/august/article21754.html" target="_blank">real est dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod te bubble that he wrote 1.5 years ago, in August 2005. The question that arises from Kiyosaki's article i cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s: Will today's sub-prime mortgage meltdown grow into the monster real estate crash that Kiyosaki predicts? Q tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ite honestly, an additional factor is the growing popularity in Real Estate Investing. Too many uninformed RE t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel investors could contribute to a real estate crash as well by selling at a loss because they financially over- ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust committed themselves. As the real estate market adjusts, the best bet is always to invest in markets and hom y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s where the cash flow is consistent and profitable. If you can't afford the risk, don't buy it. That applies . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to ARMs too. Although ARMs were great during the recession, they were a short-term solution. As the economy t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rns up, it is every investor's job to invest in assets with positive cash flow and to buy what you can afford tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:So What Is The Solution To The MLM Challenge? What About The Hype? Internet Marketing Secrets Revealed
|